208 13F filers hold it · +5 against the quarter before · shares held −0.3%
Holdings of 06/30StocksIs Wall Street adding or cutting?+5 Who bought more than 5%?5.1% What comes next?10/14 (Wed)
All tracked funds
All 5% stake reports on Xencor
Xencor XNCR
Health care sectorNasdaq
What to see in Xencor now
Vanguard Capital Management holds 5.13%
Filed 07/3110/14 estimated earnings
Due 10/14Company
- Exchange
- Nasdaq
- Sector
- Health care
- Industry
- Pharmaceutical Preparations
- Headquarters
- Pasadena, California
- Fiscal year end
- 12/31
- Next earnings
- 10/14, estimated
- 208 13F filers hold it · +5 against the quarter before · shares held −0.3%Holdings of 06/30
- Vanguard Capital Management holds 5.13%Filed 07/31
Funds
13F filers: 208 · +5 since the quarter before · 06/30 holdings
Famous funds that held Xencor in their latest 13F report.
| Fund | Value | Since the quarter before |
|---|---|---|
| Mirae Asset Global ETFS HoldingsXencor XNCR · 06/30 holdings | $611.8K | No quarter before |
| Mirae Asset Global InvestmentsXencor XNCR · 06/30 holdings | $53.4K | Trimmed −13.3% |
5% stakes
| Holder | ||
|---|---|---|
| Vanguard Capital Management07/31 | 5.13%3,810,823 sh | First report |
| EcoR1 Capital05/15 | 2.9%2,183,000 sh | −3.5pp |
| Ra Capital Management03/30 | 6.5%4,736,739 sh | First report |
| Vanguard Group03/27 | 0%0 sh | −10.0pp |
| Biotechnology Value Fund02/17 | 9.99%7,133,720 sh | +3.5pp |
| State Street02/09 | 6.3%4,507,254 sh | +1.1pp |
| RTW Investments25/11/14 | 8.7%6,221,054 sh | First report |
| Vanguard Group25/10/31 | 9.95%7,103,758 sh | −2.2pp |
| Biotechnology Value Fund25/10/17 | 6.5%4,619,341 sh | First report |
| State Street25/05/13 | 5.2%3,683,715 sh | First report |
| BlackRock25/04/29 | 15.8%11,130,112 sh | −1.6pp |
